Meta-analysis · people

Thymosin alpha-1: lower COVID-19 death risk (RR 0.59) in meta-analysis

Checked against the paper Meta-analysisPublished by PepVault

The takeaway

Pooled data tie thymosin alpha-1 to fewer COVID-19 deaths in moderate to critical illness, but not to less ventilator use or shorter hospital stays, and the authors call for randomized trials to confirm it.

Kind
Meta-analysis
Studied in
People
Published
2023
Journal
Inflammopharmacology

What they tested

The team set out to test whether thymosin alpha-1 helps people with moderate to severe COVID-19.

How the study was done

A systematic review and meta-analysis, which pools results from earlier studies. It combined data from 8 studies of people with moderate to critical COVID-19 who got thymosin alpha-1, compared with placebo, a dummy treatment.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Across the 8 studies, people given thymosin alpha-1 had a lower risk of dying from COVID-19, with a risk ratio of 0.59 (95% CI 0.37-0.93, p = 0.02). A risk ratio below 1 means lower risk in the treated group. There was no difference in the need for mechanical ventilation, a breathing machine (RR 0.83; 95% CI 0.48-1.44), or in hospital length of stay (mean difference 2.32; 95% CI -0.93 to 5.58). The death result was shaped by the size of each study and by sex.

What it doesn’t show

The pooled studies differed a lot from each other (I2 of 84% for the death result), and the effect depended on study size and sex. The authors say randomized trials are still needed to confirm the finding.

The paper

Soeroto et al. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression. Inflammopharmacology. 2023.

The compound

More studies on Thymosin Alpha-1

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo